Literature DB >> 16091471

NKG2D-independent suppression of T cell proliferation by H60 and MICA.

Anja K Kriegeskorte1, Friedemann E Gebhardt, Simona Porcellini, Matthias Schiemann, Christian Stemberger, Tobias J Franz, Katharina M Huster, Leon N Carayannopoulos, Wayne M Yokoyama, Marco Colonna, Antonio G Siccardi, Stefan Bauer, Dirk H Busch.   

Abstract

The activating receptor NKG2D recognizes a wide range of different ligands, some of which are primarily expressed in "stressed" tissues or on tumor cells. Until now, similar stimulatory effects on natural killer and CD8+ T cells have been described for all NKG2D ligands, and the NKG2D receptor/ligand system has therefore been interpreted as a sensor system involved in tumor immune surveillance and activation of immune responses. We show here that the NKG2D ligands H60 and MIC class 1 chain-related protein A (MICA) can also mediate strong suppressive effects on T cell proliferation. Responsiveness to H60- and MICA-mediated suppression requires IL-10 and involves a receptor other than NKG2D. These findings might provide explanations for the observation that strong in vivo NKG2D ligand expression, such as that on tumor cells, sometimes fails to support effective immune responses and links this observation to a distinct subgroup of NKG2D ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091471      PMCID: PMC1187963          DOI: 10.1073/pnas.0502026102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.

Authors:  D W Wolan; L Teyton; M G Rudolph; B Villmow; S Bauer; D H Busch; I A Wilson
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

2.  Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.

Authors:  C A O'Callaghan; A Cerwenka; B E Willcox; L L Lanier; P J Bjorkman
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

3.  Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.

Authors:  A Steinle; P Li; D L Morris; V Groh; L L Lanier; R K Strong; T Spies
Journal:  Immunogenetics       Date:  2001 May-Jun       Impact factor: 2.846

4.  Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.

Authors:  Lauren I Richie Ehrlich; Kouetsu Ogasawara; Jessica A Hamerman; Rayna Takaki; Alessandra Zingoni; James P Allison; Lewis L Lanier
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

5.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Authors:  D Cosman; J Müllberg; C L Sutherland; W Chin; R Armitage; W Fanslow; M Kubin; N J Chalupny
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

6.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

Authors:  A Diefenbach; A M Jamieson; S D Liu; N Shastri; D H Raulet
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

Review 7.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

8.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

9.  IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines.

Authors:  E Reali; J W Greiner; A Corti; H J Gould; F Bottazzoli; G Paganelli; J Schlom; A G Siccardi
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

10.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

Authors:  A Cerwenka; A B Bakker; T McClanahan; J Wagner; J Wu; J H Phillips; L L Lanier
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

View more
  10 in total

Review 1.  Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis.

Authors:  Mark M Davis; John D Altman; Evan W Newell
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

Review 2.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

3.  Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.

Authors:  Dongyi He; Qi Zhu; Quan Zhou; Qing Qi; Hongmei Sun; Liza M Zachariah; Grace Wang; John D Reveille; Yongtao Guan; Xiaodong Zhou
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

4.  Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

Authors:  Robert A Eagle; Insiya Jafferji; Alexander D Barrow
Journal:  Curr Immunol Rev       Date:  2009-02

Review 5.  Murine NKG2D ligands: "double, double toil and trouble".

Authors:  Asanga Samarakoon; Haiyan Chu; Subramaniam Malarkannan
Journal:  Mol Immunol       Date:  2008-12-10       Impact factor: 4.407

6.  Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin.

Authors:  Michael I Whang; Nadia Guerra; David H Raulet
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Proteasome regulation of ULBP1 transcription.

Authors:  James E Butler; Mikel B Moore; Steven R Presnell; Huei-Wei Chan; N Jan Chalupny; Charles T Lutz
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

8.  Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b.

Authors:  José M Rodríguez; Susanne Wolfrum; Megan Robblee; Kwan Y Chen; Zachary N Gilbert; Jae-Hoon Choi; Daniel Teupser; Jan L Breslow
Journal:  Circ Res       Date:  2013-08-15       Impact factor: 17.367

9.  Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.

Authors:  Qingwen Wang; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2015-11-24

10.  Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetes.

Authors:  Jian Wu; Dorothy N Kakoola; Nataliya I Lenchik; Dominic M Desiderio; Dana R Marshall; Ivan C Gerling
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.